IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharma Fine Chemicals Roundup

6:48 AM MDT | June 7, 2011 | Deepti Ramesh

Johnson Matthey's Profits Rise on Improved Demand Kerri Walsh Johnson Matthey reported net income for its fiscal year ended March 31, 2011 up 11%, to £182.7 million ($299.4 million), on sales up 27%, to £10 billion. Operating income rose 12%, to £281.2 billion. Sales excluding precious metals soared 29%, to £7.7 billion. Fine chemical sales rose by 11% because of increasing demand for its active pharmaceutical ingredients. SAFC Partners with Pfenex to Codevelop Biopharmaceuticals Alex Scott Pfenex (San Diego), an expert in protein...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa